Comparative analysis of hospitalization risk for incident heart failure in non‐Hispanic Black versus non‐Hispanic White individuals with type 2 diabetes on empagliflozin (Empa‐AA): Insights from real‐world data.

Saved in:
Bibliographic Details
Title: Comparative analysis of hospitalization risk for incident heart failure in non‐Hispanic Black versus non‐Hispanic White individuals with type 2 diabetes on empagliflozin (Empa‐AA): Insights from real‐world data.
Authors: Mishriky, Basem M.1 (AUTHOR) basem.mishriky@duke.edu, Cummings, Doyle M.2 (AUTHOR), Fu, Yuanyuan3 (AUTHOR), Halladay, Jacqueline R.4 (AUTHOR), Jones, Schuyler5 (AUTHOR), Boan, Andrea D.6 (AUTHOR), Jones, Sara7 (AUTHOR), Patil, Shivajirao P.8 (AUTHOR), Powell, James R.9 (AUTHOR), Adams, Alyssa2 (AUTHOR), Irish, William3 (AUTHOR)
Source: Diabetes, Obesity & Metabolism. May2024, Vol. 26 Issue 5, p1830-1836. 7p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:14628902
DOI:10.1111/dom.15499